Pharmacy
Upsher-Smith rolls out TORPENZ (everolimus) tablets
Upsher-Smith Launches TORPENZ (everolimus) tablets
Flu and RSV vaccine appointments now available at Rite Aid locations
Rite Aid announces availability of Flu and RSV vaccine appointments at all locations
NACDS names Stephanie Katz to advance pharmacy reimbursement priorities
Stephanie Katz will lead reimbursement, innovation, and advocacy alongside Dr. Lauren Lyles-Stolz.
Research showing added health benefits from GLP-1 drugs
Prospective health benefits from GLP-1 drugs beyond weight loss and lower blood glucose continue to emerge.
PBMs have their say in Congress; report assails industry
The House Committee on Oversight and Accountability published a report ahead of the hearing slamming PBM practices.
NACDS receives 2024 Power of Associations Silver Award
The National Association of Chain Drug Stores (NACDS) has been named a 2024 Power of Associations Silver Award winner by the American Society of Association Executives (ASAE) for its “Expanding Access to Food is Medicine Through Pharmacies” initiative.
CVS Health unveils senior-focused care centers in Chicago
The move is part of CVS Healthspire, which seeks to deliver more affordable and accessible connected patient care and pharmacy benefits across the nation.
Good Neighbor Pharmacy tops J.D. Power’s Satisfaction Index among chain drug pharmacies
Good Neighbor Pharmacy (GNP), a national franchise for independent pharmacies offered through Cencora, has been ranked “#1 in Customer Satisfaction with Chain Drug Store Pharmacies” in the J.D. Power 2024 U.S. Pharmacy Study, the company said.
J.D. Power sees traditional retail pharmacies facing new challenges
The level of trust and reliability pharmacy customers have come to expect from their local pharmacist is increasingly being found instead through mail order pharmacies. According to the J.D. Power 2024 U.S.
NACDS hails Nicholson’s appointment to Pharmacy Workgroup Steering Committee
The National Association of Chain Drug Stores is applauding the appointment of vice president of public policy, regulatory and legal affairs Kevin Nicholson to the Steering Committee for a newly established Pharmacy Workgroup within The Sequoia Project’s “Interoperability Matters” program.
Dr. Reddy’s gets positive CHMP opinion from EMA for its proposed Rituximab biosimilar
HYDERABAD, India – Dr. Reddy’s announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the launch of its proposed biosimilar Rituximab candidate DRL_RI (ITUXREDI) in European markets. Dr.
Apothecary Products expands product portfolio with acquisition of Equadose
Apothecary Products (APL) is excited to announce the acquisition of Equadose, a distinguished consumer products company renowned for its innovative health and wellness solutions.
